Qiagen

Qiagen

World Rank (Aug-2026)
2413
Market Cap (Aug-2026)
8.851 Billion USD
World Rank (Jan-05-2024)
1,657
Market Cap (Jan-05-2024)
9.994 Billion USD
World Rank (Jul-30-2023)
1,592
Market Cap (Jul-30-2023)
10.745 Billion USD
World Rank (Jan-07-2022)
1,676
Market Cap (Jan-07-2022)
11.462 Billion USD
World Rank (Jan-01-2021)
1,441
Market Cap (Jan-01-2021)
12.089 Billion USD
Headquarters Country
Netherlands
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Top Pharmaceutical Companies in Europe
Nasdaq / NYSE Code
QGEN
Employee Count
6,000
Employee Count as of Date
As on Jun-2022
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
2,090 Million USD
Annual Operating Income in USD
520 Million USD
Annual Net Income in USD
425 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
6,281 Million USD
Total Liabilities in USD
2,503 Million USD
Total Equity in USD
3,778 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Biotechnology
Technology
HealthCare Products
Company Website
QIAGEN N.V.
Wikipedia
Wikipedia
Yahoo
Yahoo @ NYSE
Company Profile

Pharmaceutical and research company with headquarters is in Germany.

Annual Results Summary

QIAGEN - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20222,141576423
Dec-20212,251 657512
Dec-20201,870 537359
Dec-20191,526 313 -41 (Loss)
Dec-20181,501 266190
Balance Sheet Summary

Total Assets as on Dec-2022 was 6,287 Million USD.

Total Liabilities as on Dec-2022 was 2,821 Million USD.

Total Equity as on Dec-2022 was 3,466 Million USD.

Founded Year
1984
Stock Category
S&P EUROPE 350
Stock Exchange
Nasdaq
NYSE
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share